David Lewis

Shares of Baxter International Inc (NYSE: BAX) are trading at a valuation that implies low growth, but Morgan Stanley sees three catalysts ahead that will likely result in top-and-bottom line acceleration into 2020. The Analyst Morgan Stanley's David Lewis upgraded Baxter from Underweight to...

Although Hologic, Inc. (NASDAQ: HOLX) acquired Cynosure to achieve a higher weighted average market growth rate, Cynosure's main businesses have not delivered as expected, according to Morgan Stanley. The Analyst Morgan Stanley’s David Lewis downgraded Hologic from Equal-weight to...

After a 10 percent drop Friday, Johnson & Johnson (NYSE: JNJ) opened Monday’s session down another 2 percent following last week’s Reuters report that the company has known about asbestos contamination in its baby powder for decades. While the potential for legal and regulatory...

The bullish case for Nevro Corp (NYSE: NVRO) — a medical device company that focuses on the treatment of chronic pain — no longer applies for three reasons, according to Morgan Stanley. The Analyst Morgan Stanley's David Lewis downgraded Nevro from Overweight to...

Intuitive Surgical, Inc. (NASDAQ: ISRG) reported Tuesday its first quarter results, which came in ahead of expectations and sent the stock surging to new all-time highs. Yet the company still faces its "most catalyst rich" cycle ever, according to Morgan Stanley. The Analyst Morgan...

An analyst at Morgan Stanley is impressed with the device pipeline at Abbott Laboratories (NYSE: ABT). The Analyst Morgan Stanley analyst David Lewis upgraded shares of Abbott Labs from Equal-Weight to Overweight and lifted the price target from $60 to $67. The Thesis Abbott Lab's...

Haemonetics Corporation (NYSE: HAE), a provider of blood and plasma services and supplies, may be benefiting from improved visibility on  its transformation, according to Morgan Stanley. Raymond James also sounded upbeat on the medical technology name, with the view that Haemonetics has...

It's a sunny day on the Detroit River, and the G3 Marquis, a 740-foot bulk carrier, is sailing downriver and has just passed underneath the Ambassador Bridge. Capt. Bill Redding and Capt. Bill Griffore board the J.W. Westcott II, a comparatively diminutive 45-foot boat, and pull up alongside...

Morgan Stanley analysts David Lewis and Jonathan Demchick raised their price target on Intuitive Surgical, Inc. (NASDAQ: ISRG) from $840 to $950. The analysts maintain an Overweight rating. Lewis and Demchick highlighted Intuitive posted five straight quarters of company-adjusted procedure...

The quiet period surrounding Irhythm Technologies Inc (NASDAQ: IRTC)'s stock has now ended after its fantastic IPO debut, so research firms are free to now evaluate the stock and issue their opinions. Here is a summary of some of the research reports, which were made available for the first time on...

Morgan Stanley analysts David Lewis and Jonathan Demchick believe Hill-Rom Holdings, Inc. (NYSE: HRC)'s story has not been fully appreciated by the Street. The analysts placed this opinion against the backdrop of the company's recent creation of a more sustainable sales base, which boosts the...

Johnson & Johnson (NYSE: JNJ)’s Q3 revenue came up short of consensus estimates, but the company managed a beat on its EPS number. The company also announced an additional $10 billion in share buybacks. Wall Street firms and the market seem split on how to interpret the company’s...